Press Releases
OTL -101 Has Received A Rare Paediadriatric Disease Announced By Orchard Therapeutics
Orchard Therapeutics Limited , a clinical-stage biotechnology company dedicated to bringing transformative autologous ex-vivo gene therapies to patients with rare diseases of high unmet...
News
Broad range of multifunctional mineral excipients
At CPhI in Frankfurt, Omya will showcase its Omyapharm® multifunctional excipient platform based on functionalized calcium carbonate, a highly structured mineral. ...
News
Technology adoption fuels growth for pharma tech firm
Zenith Technologies has strengthened its global workforce, recruiting 100 people over the past year in response to growing demand for manufacturing execution system (MES)...
Industry Reports
Valeant Pharma Announces Sale Of Obagi Medical Products Business
Valeant Pharmaceuticals International, Inc announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for...
Drug Research
Recipharm and LIDDS establish industrial manufacturing capabilities for a novel prostate cancer product
Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca®...
Interviews
Clinical Trial Disclosure Maturity Assessment Process Disclosed By TrialScope
1. In an environment where trial data is made available through peer reviewed articles how effective is clinical trial disclosure maturity assessment with increased...
Interviews
Global Clinical Trials A Insiders Take
What are the current problems or challenges faced in clinical trial payments process?There are countless challenges around clinical trial payments, but they can be...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read